DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Pipamperone is an investigational drug.
There have been 4 clinical trials for Pipamperone. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2011.
The most common disease conditions in clinical trials are Depressive Disorder, Depression, and Schizophrenia. The leading clinical trial sponsors are PharmaNeuroBoost N.V., Hannover Medical School, and [disabled in preview].
There is one US patent protecting this investigational drug and fifteen international patents.
Recent Clinical Trials for Pipamperone
|Pharmacovigilance in Gerontopsychiatric Patients||Hannover Medical School||Phase 3|
|POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophrenia||PharmaNeuroBoost N.V.||Phase 2|
|Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)||PharmaNeuroBoost N.V.||Phase 3|
Top disease conditions for Pipamperone
Top clinical trial sponsors for Pipamperone
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Pipamperone||See Pricing||Quinolone-based compounds, formulations, and uses thereof||University of South Florida (Tampa, FL) Northeastern University (Boston, MA)||See Pricing|
|Pipamperone||See Pricing||Substituted 4,5,6,7-tetrahydropyrazolo[3,4-c]pyridines as factor XIa inhibitors||Bristol-Myers Squibb Company (Princeton, NJ)||See Pricing|
|Pipamperone||See Pricing||Compositions and methods for treating Dengue virus infection||The J. David Gladstone Institutes (San Francisco, CA) The Regents of the University of California (Oakland, CA)||See Pricing|
|Pipamperone||See Pricing||Compounds useful for the treatment of metabolic disorders and synthesis of the same||North Carolina Central University (Durham, NC) The University of North Carolina at Chapel Hill (Chapel Hill, NC)||See Pricing|
|Pipamperone||See Pricing||Multivalent ligands targeting VEGFR||The Methodist Hospital System (Houston, TX)||See Pricing|
|Pipamperone||See Pricing||4-hydroxy-3-(heteroaryl)pyridine-2-one APJ agonists||Bristol-Myers Squibb Company (Princeton, NJ)||See Pricing|
|Pipamperone||See Pricing||Method for metabolomic sample preparation based on ionic liquid dispersive liquid-liquid microextraction||Agilent Technologies, Inc. (Santa Clara, CA)||See Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Pipamperone||European Patent Office||2766345||2031-10-14||See Pricing|
|Pipamperone||European Patent Office||2899183||2031-10-14||See Pricing|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|